Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Determination of Relapse Risk By Complement Gene Variants after Eculizumab Discontinuation in Complement-Mediated Thrombotic Microangiopathy: A Retrospective Review

Aldo A. Acosta-Medina, MD, Ann M. Moyer, MDPhD, Ronald S. Go, MD, Maria Alice V. Willrich, PhD, Hassan B. Alkhateeb, MD, Christianne Bourlon De Los Rios, MDMSc, Dong Chen, MD, PhD, Fernando C. Fervenza, MDPhD, Nahla M. Heikal, MD, Nelson Leung, MD, Ariela L. Marshall, MD, Cheryl L. Tran, MD, Jeffrey L. Winters, MD, Meera Sridharan, MD PhD

Blood (2020) 136 (Supplement 1): 25–26.

https://doi.org/10.1182/blood-2020-136617

Published: 2020

Journal Articles

Evaluation of Soluble Fibrin Monomer Complex in Patients with Sars-Cov-2 COVID-19 Infection

Meera Sridharan, MD PhD, Aneel A. Ashrani, MD MS, Dong Chen, MD, PhD, Nahla M. Heikal, MD, Ariela L. Marshall, MD, Rajiv K. Pruthi, M.B.B.S

Blood (2020) 136 (Supplement 1): 27–28.

https://doi.org/10.1182/blood-2020-136717

Published: 2020

Journal Articles

Differential Effect of Rituximab on Relapse-Free Survival in De Novo and Relapsed Immune Thrombotic Thrombocytopenic Purpura in African-American and Caucasian Populations

Blood (2019) 134 (Supplement_1): 90.

https://doi.org/10.1182/blood-2019-129383

Published: 2019

Journal Articles

African American Race Is Associated with Decreased Relapse-Free Survival in Immune Thrombotic Thrombocytopenic Purpura

Blood (2019) 134 (Supplement_1): 1066.

https://doi.org/10.1182/blood-2019-131064

Published: 2019

Journal Articles

Efficacy and Safety of Prothrombin Complex Concentrate (PCC) for Direct Oral Anticoagulant Reversal: A Single Institutional Experience

Meera Sridharan, MD, Narith N Ou, Pharm.D., R.Ph, Lance J. Oyen, Pharm.D., R.Ph, Aneel A. Ashrani, MD, M.S., Robert D. McBane, MD, Rajiv K. Pruthi, M.B.B.S.

Blood (2018) 132 (Supplement 1): 2533.

https://doi.org/10.1182/blood-2018-99-112227

Published: 2018

Journal Articles

Practice Patterns for Diagnosis of Type 1 Von Willebrand Disease and Effect of Age on Von Willebrand Factor Levels: A Single Institutional Retrospective Study

Meera Sridharan, MD, Sandra Heisler, L.P.N, Jansen Seheult, MD MB, BC, BAO, William L. Nichols, MD, Rajiv K. Pruthi, M.B.B.S.

Blood (2018) 132 (Supplement 1): 1183.

https://doi.org/10.1182/blood-2018-99-119137

Published: 2018

Journal Articles

Clinical Associations, Treatment, and Outcomes of Renal-Limited Thrombotic Microangiopathy

Elias Simon Saba, BS, Julia Claire Cambron, BS, Ronald S. Go, MD, Nelson Leung, MD, Meera Sridharan, MD

Blood (2018) 132 (Supplement 1): 4978.

https://doi.org/10.1182/blood-2018-99-117723

Published: 2018

Journal Articles

A Descriptive Analysis of the Demographics and Presenting Symptoms of Patients in the U.S. Thrombotic Microangiopathy (USTMA) TTP Registry

Elizabeth Davis, Ana G. Antun, MD, Lisa Baumann Kreuziger, MD MS, J. Evan Sadler, MD PhD, Spero R Cataland, MD, Meera Sridharan, MD, Todd Clover, MD, Andrew Johnson, MD, Keith McCrae, MD, Shruti Chaturvedi, MBBS,MS, Ronald S. Go, MD, Ming Yeong Lim, MBBChir, Marshall A. Mazepa, MD

Blood (2017) 130 (Supplement 1): 1049.

https://doi.org/10.1182/blood.V130.Suppl_1.1049.1049

Published: 2017

Journal Articles

Factors Associated with Mortality in Immune-Mediated Thrombotic Thrombocytopenic Purpura: Results from the United States Thrombotic Microangiopathy TTP Registry

Todd Clover, MD MS, Ronald S. Go, MD, Ana G. Antun, MD, Spero R Cataland, MD, Shruti Chaturvedi, MBBS,MS, Elizabeth Davis, Andrew Johnson, MD, Ming Yeong Lim, MBBChir, Meera Sridharan, MD, Keith McCrae, MD, J. Evan Sadler, MD PhD, Marshall A. Mazepa, MD, Lisa Baumann-Kreuziger, MS MD

Blood (2017) 130 (Supplement 1): 3624.

https://doi.org/10.1182/blood.V130.Suppl_1.3624.3624

Published: 2017

Journal Articles

The Impact of Detectable ADAMTS13 Inhibitor on the Clinical Presentation and Outcome of Patients with Immune Thrombotic Thrombocytopenic Purpura (iTTP): Analysis Using the United States Thrombotic Microangiopathy (USTMA) Clinical Registry

Meera Sridharan, MD, Ana G Antun, MD, Lisa Baumann Kreuziger, Assistant Professor. MD MS, Spero R Cataland, MD, Shruti Chaturvedi, MBBS,MS, Todd Clover, MD, Elizabeth Davis, Andrew Johnson, MD, Keith McCrae, MD, Ming Yeong Lim, MBBChir, J. Evan Sadler, MD PhD, Marshall A. Mazepa, MD, Ronald S Go, MD

Blood (2017) 130 (Supplement 1): 3620.

https://doi.org/10.1182/blood.V130.Suppl_1.3620.3620

Published: 2017

Journal Articles

Atypical Hemolytic Uremic Syndrome-Clinical Presentation, Treatment, and Short Term Outcomes: The Mayo Clinic Experience

Meera Sridharan, MD, Roshini Abraham, PhD, Hatem Amer, MD, Fernando Fervenza, MD, C. Christopher Hook, MD, Nelson Leung, MD, Ariela L. Marshall, MD, David L. Murray, MDPhD, Rajiv K. Pruthi, MBBS, Sanjeev Sethi, MDPhD, Maria Alice V. Willrich, PhD, Jeffrey L. Winters, MD, Ronald S. Go, MD

Blood (2017) 130 (Supplement 1): 2317.

https://doi.org/10.1182/blood.V130.Suppl_1.2317.2317

Published: 2017

Journal Articles

The Mayo Clinic Experience with Diagnosis and Treatment of Gardner-Diamond Syndrome

Meera Sridharan, MD, Uzma Ali, Rajiv K. Pruthi, MD, C Christopher Hook, MD, William L. Nichols, Jr., MD

Blood (2016) 128 (22): 3779.

https://doi.org/10.1182/blood.V128.22.3779.3779

Published: 2016

Journal Articles

Management Of PICC-Associated Thrombosis In Patients Receiving Chemotherapy For Hematologic Malignancies

Meera Sridharan, MD, PhD, Aref Al-Kali, MD, Aneel A. Ashrani, MBBS, MSc, Kebede Begna, MD, Michelle Elliott, William J. Hogan, MBChB, Carl C. Hook, MD, Scott H. Kaufmann, MD, PhD, Louis Letendre, MD, Mark R. Litzow, MD, Mrinal M. Patnaik, MBBS, Animesh D. Pardanani, MBBS, PhD, Ayalew Tefferi, MD, Alexandra Wolanskyj, MD, Rajiv K. Pruthi, MBBS

Blood (2013) 122 (21): 5000.

https://doi.org/10.1182/blood.V122.21.5000.5000

Published: 2013

NARROW

Determination of Relapse Risk By Complement Gene Variants after Eculizumab Discontinuation in Complement-Mediated Thrombotic Microangiopathy: A Retrospective Review

Evaluation of Soluble Fibrin Monomer Complex in Patients with Sars-Cov-2 COVID-19 Infection

Differential Effect of Rituximab on Relapse-Free Survival in De Novo and Relapsed Immune Thrombotic Thrombocytopenic Purpura in African-American and Caucasian Populations

African American Race Is Associated with Decreased Relapse-Free Survival in Immune Thrombotic Thrombocytopenic Purpura

Efficacy and Safety of Prothrombin Complex Concentrate (PCC) for Direct Oral Anticoagulant Reversal: A Single Institutional Experience

Practice Patterns for Diagnosis of Type 1 Von Willebrand Disease and Effect of Age on Von Willebrand Factor Levels: A Single Institutional Retrospective Study

Clinical Associations, Treatment, and Outcomes of Renal-Limited Thrombotic Microangiopathy

A Descriptive Analysis of the Demographics and Presenting Symptoms of Patients in the U.S. Thrombotic Microangiopathy (USTMA) TTP Registry

Factors Associated with Mortality in Immune-Mediated Thrombotic Thrombocytopenic Purpura: Results from the United States Thrombotic Microangiopathy TTP Registry

The Impact of Detectable ADAMTS13 Inhibitor on the Clinical Presentation and Outcome of Patients with Immune Thrombotic Thrombocytopenic Purpura (iTTP): Analysis Using the United States Thrombotic Microangiopathy (USTMA) Clinical Registry

Atypical Hemolytic Uremic Syndrome-Clinical Presentation, Treatment, and Short Term Outcomes: The Mayo Clinic Experience

The Mayo Clinic Experience with Diagnosis and Treatment of Gardner-Diamond Syndrome

Management Of PICC-Associated Thrombosis In Patients Receiving Chemotherapy For Hematologic Malignancies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only